SGS Expands Phase I Capacity

SGS Life Science Services expanded its Phase I Unit in Antwerp, Belgium, adding 22 new hospitalization beds to its clinical pharmacology unit in the Stuivenberg hospital. This addition includes a new subunit of six wards with 3-5 beds, a new recreational room, sample preparation lab, and additional auxiliary services, bringing the total number of beds to 102 for Belgium, and the company’s global capacity to 184 beds.

The additional beds and auxiliary services will be used to support larger trials. Also, this new subunit can be isolated from the others and used for smaller stand-alone trials running in parallel. The new infrastructure is in place and is scheduled for use in several upcoming trials.

“We wanted to boost the capacity of the unit to increase our flexibility in study scheduling, which will be a significant advantage for our clients. This extension allows us to maintain the same level of quality that has always existed at SGS,” said Omer Van Schoor, the director of clinical pharmacology at the SGS Antwerp facility.